Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma. - Kacimi SEO; Dehais C; Feuvret L; Chinot O; Carpentier C; Bronnimann C; Vauleon E; Djelad A; Cohen-Jonathan Moyal E; Langlois O; Campone M; Ducloie M; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)